OpenVSafe by OpenVAERS
Search V-safe

8RV-96868-86055

4 vaccinations 9 coded responses 22 check-ins 9 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
837 / ID
Registered
2021-02-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-23
    Registered in v-safe
  3. 2021-02-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  5. 2021-02-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  6. 2021-02-28
    Survey response — day 7, dose 1
    MedDRA: No adverse event — Feeling: Fair · Fatigue or tiredness
    Free text: Nothing not previously evident.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-11
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  8. 2021-03-14
    Survey response — day 21, dose 1
    MedDRA: Dyspnoea exertional — Feeling: Fair
    Free text: Dysonea on Exertion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-15
    Dose 2 — Pfizer-BioNTech
  10. 2021-03-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Exubérant nadal drainage.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-03-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Upper-airway cough syndrome — Feeling: Good
    Free text: Excess watery no sal drainage less.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-03-24
    Survey response — day 7, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-03-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-05
    Survey response — day 21, dose 2
    MedDRA: Dyspnoea exertional — Feeling: Good
    Free text: Mild dyspnea with exertion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-09-13
    Survey response — 6 months, dose 2
    MedDRA: Hospitalisation, Syncope, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Syncopal episodewhileseated improved within 15 minuteHospitalized overnight. Negative CT brain.,Negative/unchanged EKG. Normal CXR. 14 day ZioXT monitor now. In process. Symptoms restricted to approximately 15 minutes including immediate recovery. · Healthcare visit (other): See above.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-09-13
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-09-16
  22. 2021-09-17
  23. 2021-10-02
    Dose 3 — Pfizer-BioNTech
  24. 2022-03-15
    Survey response — 12 months, dose 2
    MedDRA: Abnormal sleep-related event, Avulsion fracture, Crying, Hand fracture, Injury, Lacrimation increased, Limb injury, Rhinorrhoea, Tendon injury — Feeling: Good
    Free text: 1. Trauma. Avulsion fx of left third finger distal joint with disruption of tendon. Caught in car door. 2. Persistently recurrent weeping of eyes. No primary nasal symptoms but watery eyes revealed in nasal drip. 3. Highly variable sleep patterns.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-03-30
    Dose 4 — Pfizer-BioNTech
  26. 2022-05-05
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  27. 2022-05-13
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-07-01
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  29. 2022-09-28
    Survey response — 6 months, dose 4
    MedDRA: Fatigue — Feeling: Fair
    Free text: Easy fatilabilty
    MedDRA releases: 2024-11 · check-in free text available
  30. 2023-03-30
    Health check-in — 12 months, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-21Pfizer-BioNTech
22021-03-15Pfizer-BioNTech
32021-10-02Pfizer-BioNTech No
42022-03-30Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 4 — day 7, dose 1

2021-02-28

Systemic reaction (other): Nothing not previously evident.

Release 5 — day 21, dose 1

2021-03-14

Symptoms: Dysonea on Exertion.

Release 6 — days 1–6 daily, dose 2

2021-03-20

Systemic reaction (other): Exubérant nadal drainage.

2021-03-21

Systemic reaction (other): Excess watery no sal drainage less.

Release 6 — day 7, dose 2

2021-03-24

Systemic reaction (other): No

Release 6 — day 21, dose 2

2021-04-05

Symptoms: Mild dyspnea with exertion

Release 9 — 6 months, dose 2

2021-09-13

Symptoms: Syncopal episodewhileseated improved within 15 minuteHospitalized overnight. Negative CT brain.,Negative/unchanged EKG. Normal CXR. 14 day ZioXT monitor now. In process. Symptoms restricted to approximately 15 minutes including immediate recovery.
Healthcare visit (other): See above.

Release 11 — 12 months, dose 2

2022-03-15

Symptoms: 1. Trauma. Avulsion fx of left third finger distal joint with disruption of tendon. Caught in car door. 2. Persistently recurrent weeping of eyes. No primary nasal symptoms but watery eyes revealed in nasal drip. 3. Highly variable sleep patterns.

Release 12 — 6 months, dose 4

2022-09-28

Symptoms: Easy fatilabilty

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDAbnormal sleep-related event · · ✓
SDAvulsion fracture · · ✓
SDCrying · · ✓
SDDyspnoea exertional ✓ ✓ ✓
SDFatigue · · ✓
SDHand fracture · · ✓
SDHospitalisation · · ✓
SDInjury · · ✓
SDLacrimation increased · · ✓
SDLimb injury · · ✓
SDRhinorrhoea · · ✓
SDSyncope · · ✓
SDTendon injury · · ✓
SRONo adverse event ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓
SROUpper-airway cough syndrome ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release